Completed Infection & Immunity Cells, Biochemistry & Physiology
Discovery & Development of Broadly Reactive Fully Human Monoclonal Antibodies as Candidates for Treatment of Ebola Virus Disease
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at Theraclone Sciences.
View the original record at the funder ↗
Researchers
Kristine Swiderek (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Development of monoclonal antibody therapeutics for ebolavirus infection
Emergency Evaluation of Treatments for Ebola Virus Disease
Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) during Ebola virus infection in non-human primates humans
Harnessing the structural flexibility of bovine monoclonal antibodies for the treatment of emerging virus infections
Emergency evaluation of convalescent blood and plasma for Ebola Viral Disease (EVD) in affected West African countries.
Original classification
Ebola Research Support InitiativePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know